DUBLIN--(BUSINESS WIRE)--The "PD-1 x VEGF and PD-L1 x VEGF Bispecific Antibodies: A Business, Pipeline And Competitor Analysis From An Industry Perspective" report has been added to ...

Researchers from Vicero Inc. have developed a Vincobody platform, which allows for design of novel proprietary VHH antibody fragments that possess the efficacy of dual checkpoint blockade while ...

A novel two-drug combination exhibited antitumor activity among certain women with advanced endometrial cancer, data ...

The global bispecific antibody (BsAb) market has witnessed significant growth, with 17 bispecific antibody therapies already ...

Combination treatment with cadonilimab and lenvatinib can produce responses in patients with advanced endometrial cancer.

INNOVENT BIO (01801.HK) is working with a consultant to gauge the interest of global pharmaceutical companies in its ...

INNOVENT BIO (01801.HK) is working with a consultant to gauge the interest of global pharmaceutical companies in its self-developed pioneered PD-1/IL-2 Alpha-bias bispecific antibodies fusion ...